HomeSBS • ETR
add
Stratec SE
Previous close
€27.70
Day range
€26.45 - €27.50
Year range
€26.45 - €48.60
Market cap
333.73M EUR
Avg Volume
3.82K
P/E ratio
32.12
Dividend yield
2.08%
Primary exchange
ETR
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 57.23M | -8.69% |
Operating expense | 14.30M | 49.36% |
Net income | 549.00K | -89.26% |
Net profit margin | 0.96 | -88.24% |
Earnings per share | — | — |
EBITDA | 7.08M | -45.92% |
Effective tax rate | 34.01% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.11M | 65.06% |
Total assets | 450.84M | 1.75% |
Total liabilities | 223.08M | 2.68% |
Total equity | 227.76M | — |
Shares outstanding | 12.16M | — |
Price to book | 1.48 | — |
Return on assets | 1.24% | — |
Return on capital | 1.47% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 549.00K | -89.26% |
Cash from operations | 8.05M | 18.80% |
Cash from investing | -3.66M | 90.04% |
Cash from financing | -1.86M | 2.47% |
Net change in cash | 2.95M | 109.19% |
Free cash flow | -6.18M | -303.79% |
About
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic OEM supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
Founded
1979
Website
Employees
1,462
